- Home
- OLMA vs PRGO Comparison
OLMA vs PRGO Comparison
Compare OLMA & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OLMA | PRGO |
|---|---|---|
| Founded | 2006 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 2020 | 2013 |
Fundamental Metrics
Financial Performance| Metric | OLMA | PRGO |
|---|---|---|
| Price | $14.71 | $9.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 3 |
| Target Price | ★ $41.13 | $19.33 |
| AVG Volume (30 Days) | 1.5M | ★ 3.3M |
| Earning Date | 01-01-0001 | 05-29-2026 |
| Dividend Yield | N/A | ★ 12.31% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.02 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.86 | $9.25 |
| 52 Week High | $36.26 | $29.08 |
Technical Indicators
Market Signals| Indicator | OLMA | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 20.04 | 16.27 |
| Support Level | $4.35 | N/A |
| Resistance Level | $27.38 | $14.84 |
| Average True Range (ATR) | 1.35 | 0.64 |
| MACD | -0.94 | -0.38 |
| Stochastic Oscillator | 3.20 | 0.54 |
Price Performance
Historical ComparisonAbout OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.